Correlation Between Pennant and Xenetic Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pennant and Xenetic Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pennant and Xenetic Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pennant Group and Xenetic Biosciences, you can compare the effects of market volatilities on Pennant and Xenetic Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pennant with a short position of Xenetic Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pennant and Xenetic Biosciences.

Diversification Opportunities for Pennant and Xenetic Biosciences

PennantXeneticDiversified AwayPennantXeneticDiversified Away100%
0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pennant and Xenetic is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Pennant Group and Xenetic Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xenetic Biosciences and Pennant is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pennant Group are associated (or correlated) with Xenetic Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xenetic Biosciences has no effect on the direction of Pennant i.e., Pennant and Xenetic Biosciences go up and down completely randomly.

Pair Corralation between Pennant and Xenetic Biosciences

Given the investment horizon of 90 days Pennant Group is expected to generate 0.53 times more return on investment than Xenetic Biosciences. However, Pennant Group is 1.87 times less risky than Xenetic Biosciences. It trades about 0.06 of its potential returns per unit of risk. Xenetic Biosciences is currently generating about 0.02 per unit of risk. If you would invest  1,209  in Pennant Group on December 11, 2024 and sell it today you would earn a total of  1,040  from holding Pennant Group or generate 86.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pennant Group  vs.  Xenetic Biosciences

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -25-20-15-10-505
JavaScript chart by amCharts 3.21.15PNTG XBIO
       Timeline  
Pennant Group 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pennant Group has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar222426283032
Xenetic Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Xenetic Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
JavaScript chart by amCharts 3.21.15JanFebMarFebMar3.73.83.944.14.24.34.4

Pennant and Xenetic Biosciences Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-4.38-3.28-2.18-1.08-0.01510.891.82.713.62 0.0400.0450.0500.0550.060
JavaScript chart by amCharts 3.21.15PNTG XBIO
       Returns  

Pair Trading with Pennant and Xenetic Biosciences

The main advantage of trading using opposite Pennant and Xenetic Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pennant position performs unexpectedly, Xenetic Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xenetic Biosciences will offset losses from the drop in Xenetic Biosciences' long position.
The idea behind Pennant Group and Xenetic Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency